Author's abstract
The work performed by the clinical chemist may deeply affect the decisions ofthe doctor and the well-being ofthe patient. Yet in contrast to the doctor and to the nurse the clinical chemist usually has nopersonal relationship with thepatient. Being encumbered by much technology and anonymity is itselfa reasonfor scrutinising his involvement in issues ofhealth care ethics. This is an attempt at clarifyingsome major aspects: the relationship ofhisprofessional ethics to medical ethics as a whole, his ethical obligations to thepatient and to society, and other aspects. The assertion that clinical chemists may have to bear some co-responsibility for decisions in dilemmas of medical ethics, is more likely to cause raised eyebrows than heated debates amongst the public. Of the millions of people who undergo treatment in hospitals most return home without ever having set eyes on a clinical chemist or being in the least aware of his existence. I think, however, that the inconspicuous nature of the work of the laboratory scientist is one more reason why its ethical implications deserve special inquiry.
That clinical chemists can become involved in issues ofmedical ethics is illustrated by the following:
(I) The known chemistry of intermediary metabolism has attained such a degree of complexity that it may be difficult for clinicians to keep abreast ofthe progress in this field. The specialised clinical chemist may be more competent in assessing the risks of a decision, for example, pertaining to a patient with a novel inborn error of metabolism. If the clinician must rely heavily on the advice ofthe clinical chemist for the treatment of the patient, or for genetic counselling, can one still maintain that the responsibility of the chemist consists only of providing laboratory results and biochemical commentary? Clinical chemists who have become consultants in such delicate decisions usually feel only too clearly the ethical responsibility they must share although the final ethical and, of course, the legal responsibility, clearly rest with the clinician in charge of the patient. Knowing that his advice will be accepted increases the share of responsibility of the clinical chemist. The burden of responsibility may be perceived to be quite heavy if a controversy arises and the clinical chemist feels that he must question the diagnosis or treatment chosen by the physician. (II) oc 1-fetoprotein determination in amniotic fluid has become a routine procedure of prenatal diagnosis for saving mothers from the fate of giving birth to babies with severe neural tube defects. Yet its introduction has aroused considerable controversy. Some feel that the test should be applied only to mothers at risk who request it, and who also accept the consequent termination of the pregnancy if indicated. Others feel that it should be applied to all pregnant women. In the USA a proposal has been submitted to the Food and Drug Administration that test kits for oc 1- catastrophes that had been deliberately perpetrated. He became no less alarmed by modern technological man who unwittingly and lightheartedly plays his part in eroding his own freedom and in inconspicuously destroying the humane element in the fabric ofsociety.
It appears that Anders and Jonas, independently, reached the conclusion that three factors were crucial: 1) Technology enables man to produce effects that transcend the capacity of his imagination, by just pressing a button. 2) There is now a temptation, fostered by adventurous and commercial interests, to realise immediately and exploit every new possibility that has been opened up by science and technology. 3) A strict division of work according to professional specialties and functional assignments means everybody is supposed to carry out isolated orders without ascertaining or questioning their ultimate goal.
Proposals for the ethics ofclinical chemistry
The lesson we learn from our philosophers is that the attack on humanity can be launched without any devilish design, by the blind dynamics of scientific research, technology and commerce which are ethically uncontrolled. Our first duty is to develop an attitude of informed sensitivity to the humane implications of our decisions. We should always seek an understanding of the totality of the goal for which our co-operation is requested, and not carry out orders in blind trust and blind compliance.
The observations of our philosophers on man in the maze oftechnology certainly deserve our earnest consideration and so do their conclusions. One may, how- Figure 2 group.bmj.com on March 31, 2017 -Published by http://jme.bmj.com/ Downloaded from ever, doubt whether their rather general advice can be translated into practical ethical guidelines for clinical chemistry (and other professions). Has philosophical analysis ever stopped processes of dehumanisation? Have Hippocratic oaths and ethical codes any influence on human behaviour unless they are backed by legal enforcement? Clinical chemistry is but one, numerically not very impressive section, of the many specialties of health care. Will a revision of our ethical standards have any effect without a simultaneous revision of the total structure of health care? Can the structure of health care be improved without changing the field of social forces in which it functions? Whoever seeks to cure the ills of any one, single, branch of our highly complex society is likely to encounter such frustrating, seemingly rhetorical questions. One might feel a desperate desire to 'redeem' society by violent revolution, or just to do nothing. I think we should yield to neither of these temptations, but should rather commit ourselves to piecemeal improvement. It is with such unassuming intentions that I have submitted to the International Federation of Clinical Chemistry (IFCC) a number of proposals, of which I mention here the following:
A: Ethical rules for clinical chemistry on two levels (i) Practical ethical guidelines should be worked out at national levels to allow for the great variety of specialists and their status and function in different countries.
(ii) The fundamental principles, however, on which the guidelines are to be based, should be agreed on in an ethical convention ofthe IFCC similar to the ethical conventions of other health care professions. This convention should comprise both disciplinary and aspirational elements (6). B: Ethical problems should be discussed not only in special books on ethics but also in the context ofpractical issues oflaboratory medicine.
C: Sensitivity in issues of medical ethics should be one of the requirements for the appointment of clinical chemists and their co-workers. Recruitment and promotion policy for clinical chemistry can have a decisive influence on the professional morale in our laboratories. However, a major problem is the criteria we use to select candidates. We have much to learn from the successes and failures of medical schools that have been grappling with similar problems, as witnessed by unending discussions in journals of medical education.
